DrugPatentWatch Database Preview
Litigation Details for Bristol-Myers Squibb Company v. Aurobindo Pharma USA Inc. (D. Del. 2017)
Email this page to a colleague
» See Plans and PricingBristol-Myers Squibb Company v. Aurobindo Pharma USA Inc. (D. Del. 2017)
| Docket | Start Trial | Date Filed | 2017-04-05 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | ACCORD HEALTHCARE INC.; APOTEX CORP.; APOTEX INC.; AUROBINDO PHARMA LTD.; AUROBINDO PHARMA USA INC.; BIONPHARMA INC.; BRISTOL-MYERS SQUIBB COMPANY; DR. REDDY'S LABORATORIES INC.; DR. REDDY'S LABORATORIES LTD.; EMCURE PHARMACEUTICALS LTD.; HEC PHARM USA INC.; HETERO LABS LTD.; HETERO LABS LTD. UNIT-V; HETERO USA INC.; IMPAX LABORATORIES INC.; IMPAX LABORATORIES LLC; INDOCO REMEDIES LTD.; INVAGEN PHARMACEUTICALS INC.; LUPIN LTD.; MACLEODS PHARMACEUTICALS LTD.; MICRO LABS LTD.; MICRO LABS USA INC.; MYLAN PHARMACEUTICALS INC.; NATCO PHARMA LTD.; PFIZER INC.; PRINSTON PHARMACEUTICAL INC.; SANDOZ INC.; SIGMAPHARM LABORATORIES LLC; SUN PHARMA GLOBAL FZE; SUN PHARMACEUTICAL INDUSTRIES INC.; SUNSHINE LAKE LLC; SUNSHINE LAKE PHARMA CO. LTD.; TORRENT PHARMACEUTICALS LTD.; UNICHEM LABORATORIES, LTD.; WOCKHARDT BIO AG; WOCKHARDT USA LLC; ZYDUS PHARMACEUTICALS (USA) INC. | ||
| Patents | 6,017,927; 6,967,208; 9,326,945 | ||
| Attorneys | A. Neal Seth; Adam Wyatt Poff; Alexis Cohen; Amy K. Wigmore; Andrew J. Danford; Andrew J. Miller; Annaleigh E. Curtis; Anthony J. Fitzpatrick; Arthur G. Connolly , III; Arun John Mohan; Bindu Ann George Palapura; Brandon M. White; Brian E. Farnan; C. Kyle Musgrove; Carolyn A. Alenci; Carolyn A. Blessing; Charles T. Cox , Jr.; Christa J. Laser; David A. Bilson; David A. Gerasimow; David B. Abramowitz; David Ellis Moore; David Jay; Dean L. Fanelli; Devan V Padmanabhan; Dominick T. Gattuso; Don J. Mizerk; Douglas R. Weider; Dustin L. Taylor; Elena Endrukaite; Elizabeth M. Crompton; Erin M. Forbes; Erin R. Conway; Eve H. Ormerod; Gregory Erich Stuhlman; Heather M. Petruzzi; Jamaica P. Szeliga; Jeffrey T. Hantson; Jennifer M. Rutter; Jill M. Browning; John C. Phillips , Jr.; John M. Seaman; Jonathan B. Turpin; Joseph E. Cwik; Joseph J. Farnan , Jr.; Karen L. Carroll; Karen L. Pascale; Katherine P. Kieckhafer; Katie A. Boda; Keith D. Parr; Kenneth Laurence Dorsney; Kevin M. Capuzzi; Kevin M. Yurkerwich; Kevin P. Burke; Kevin S. Prussia; Kimberly A. Beis; Madeleine C. Laupheimer; Maegan A. Fuller; Manish K. Mehta; Marc R. Wezowski; Matthew M. Holub; Melanie B. Dubis; Michael Choi; Michael J. Farnan; Michael J. Fink; Michael J. Gaertner; Michael Nelson; Micheal L. Binns; Natco Pharma Ltd.; Neal C. Belgam; Nina Vachhani; P. Branko Pejic; Paul A. Braier; Paul H. Kochanski; Philip D. Segrest; Rachel K. Hunnicutt; Richard L. Renck; Robert L. Florence; Scott Cunning; Sean M. Brennecke; Sharad K. Bijanki; Shirley Cantin; Sri K. Sankaran; Stamatios Stamoulis; Stephanie E. O'Byrne; Stephen B. Brauerman; Stephen P. Benson; Steven J. Moore; Stuart D. Sender; Tara M. Raghaven; Thomas A. Haag; Thomas P. Heneghan; Thomas R. Burns; Timothy Cook; Tracey C. Allen; Vincent L. Capuano; Wenbo Zhang; Wenli Gu; William A. Rakoczy; William F. Lee; Zaiba Baig | ||
| Firms | Abrams & Bayliss LLP; Bayard, P.A.; Benesch Friedlander Coplan & Aronoff LLP; Connolly Gallagher LLP; Duane Morris, LLP; Farnan LLP; Greenberg Traurig, the Nemours Building; Heyman Enerio Gattuso & Hirzel LLP; Klehr Harrison Harvey Branzburg & Ellers; Phillips, Goldman, McLaughlin & Hall, P.A.; Schiff Hardin LLP; Smith, Katzenstein, & Jenkins LLP; Stamoulis & Weinblatt LLC; Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Bristol-Myers Squibb Company v. Aurobindo Pharma USA Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial and Start Trial .
Details for Bristol-Myers Squibb Company v. Aurobindo Pharma USA Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | 12 | Answer to Complaint | IV) for U.S. Patent Nos. 6,967,208 (“the ’208 patent”) and 9,326,945 (“the ’945 patent”). Aurobindo … (Noninfringement of U.S. Patent No. 6,967,208) Plaintiffs will not and cannot…Invalidity of U.S. Patent No. 6,967,208) Upon… purports to bring an action for patent infringement under the Patent Laws, 35 U.S.C. § 100 et seq… PATENTS-IN-SUIT 9. Aurobindo admits that the ’208 patent is entitled “ | External link to document |
| 0000-00-00 | 144 | Notice of Service | Invalidity Contentions Relating to U.S. Patent No. 6,967,208 filed by Mylan Pharmaceuticals Inc..(Stamoulis… 5 April 2017 1:17-cv-00374 830 Patent None District Court, D. Delaware | External link to document |
| 0000-00-00 | 145 | Notice of Service | Invalidity Contentions Relating to U.S. Patent No. 9,326,945 filed by Mylan Pharmaceuticals Inc..(Stamoulis… 5 April 2017 1:17-cv-00374 830 Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
